UNIGE document Scientific Article
previous document  unige:7371  next document
add to browser collection
Title

Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Authors
Kaufmann, G. R.
Furrer, Hansjakob
Ledergerber, Bruno
Perrin, Luc
Opravil, Milos
Vernazza, Pietro
Cavassini, Matthias
Bernasconi, Enos
show hidden authors show all authors [1 - 11]
Published in Clinical Infectious Diseases. 2005, vol. 41, no. 3, p. 361-372
Abstract BACKGROUND: The CD4 T cell count recovery in human immunodeficiency virus type 1 (HIV-1)-infected individuals receiving potent antiretroviral therapy (ART) shows high variability. We studied the determinants and the clinical relevance of incomplete CD4 T cell restoration. METHODS: Longitudinal CD4 T cell count was analyzed in 293 participants of the Swiss HIV Cohort Study who had had a plasma HIV-1 RNA load <1000 copies/mL for > or =5 years. CD4 T cell recovery was stratified by CD4 T cell count 5 years after initiation of ART (> or =500 cells/microL was defined as a complete response, and <500 cells/microL was defined as an incomplete response). Determinants of incomplete responses and clinical events were evaluated using logistic regression and survival analyses. RESULTS: The median CD4 T cell count increased from 180 cells/microL at baseline to 576 cells/microL 5 years after ART initiation. A total of 35.8% of patients were incomplete responders, of whom 47.6% reached a CD4 T cell plateau <500 cells/microL. Centers for Disease Control and Prevention HIV-1 disease category B and/or C events occurred in 21% of incomplete responders and in 14.4% of complete responders (P>.05). Older age (adjusted odds ratio [aOR], 1.71 per 10-year increase; 95% confidence interval [CI], 1.21-2.43), lower baseline CD4 T cell count (aOR, 0.37 per 100-cell increase; 95% CI, 0.28-0.49), and longer duration of HIV infection (aOR, 2.39 per 10-year increase; 95% CI, 1.19-4.81) were significantly associated with a CD4 T cell count <500 cells/microL at 5 years. The median increases in CD4 T cell count after 3-6 months of ART were smaller in incomplete responders (P<.001) and predicted, in conjunction with baseline CD4 T cell count and age, incomplete response with 80% sensitivity and 72% specificity. CONCLUSION: Individuals with incomplete CD4 T cell recovery to <500 cells/microL had more advanced HIV-1 infection at baseline. CD4 T cell changes during the first 3-6 months of ART already reflect the capacity of the immune system to replenish depleted CD4 T lymphocytes.
Keywords Adult — Anti-HIV Agents/ therapeutic use — CD4 Lymphocyte Count — CD8-Positive T-Lymphocytes — Cohort Studies — Female — HIV Infections/ drug therapy — Humans — Logistic Models — Male — Middle Aged — Multivariate Analysis — Odds Ratio — RNA, Viral/blood — Risk Factors — Time Factors — Viral Load
Identifiers
PMID: 16007534
Full text
Article - document accessible for UNIGE members only Limited access to UNIGE
Structures
Faculté de médecine / Section de médecine clinique / Département de médecine
Citation
(ISO format) 		KAUFMANN, G. R. et al. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. In: Clinical Infectious Diseases, 2005, vol. 41, n° 3, p. 361-372. https://archive-ouverte.unige.ch/unige:7371

282 hits

0 download

Contact an author

Update request

Update

Deposited on : 2010-06-21

Export document
Format :
Citation style :